Key facts
- Enifer’s last known valuation is $54.9M (May 2024).
- It has raised $35.0M; the latest was Later Stage VC ($5.8M) in Mar 2026.
- Notable investors include Plug and Play Tech Center, EIT Food, European Union, Tesi, VTT Technical Research Centre of Finland — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Enifer
- ·The full record, as it builds
Funding rounds
No funding rounds for Enifer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enifer
Developer of a biotech protein product designed to bring a sustainability leap to fish farming. The company offers a form of single-cell protein derived from fungi, Pekilo mycoprotein, nutritious and protein-rich cell biomass to modify circular economy by-products into planet-friendly protein, enabling modern biorefineries to convert their underutilized side or waste streams into valuable protein-rich feed.
- Sector
- Business Products and Services (B2B)
- HQ
- Espoo, Finland
- Founded
- 2019
- Employees
- 38
- Website
- enifer.com/
- Ownership
- Privately Held (backing)
Enifer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enifer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enifer in its N-PORT filings yet. We sweep new filings monthly.